Based on GMP and ISO quality systems, we apply precise separation, structural modification, and aseptic control technologies to produce high-purity pharmaceutical raw materials such as glycyrrhetinic acid and monoammonium glycyrrhizinate S, ensuring stable composition, controllable impurities, and clear efficacy to meet registration standards for injections, oral formulations, and dermatological preparations.
Licorice flow infusion
Glycyrrhizic acid monoammonium salt S
Glycyrrhizic acid monoammonium salt S
Licorice extract
Built around pharmacopoeia standards and clinical-grade quality control, this portfolio focuses on high-purity licorice actives for human pharmaceutical development.
Human Pharma Portfolio / 3
Glycyrrhiza Liquid Extract
Applications
Raw material for antitussive and expectorant Chinese medicines such as pediatric cough syrup and compound glycyrrhiza oral solution
Highlights
Pharmacological effects
Glycyrrhiza Liquid Extract is a commonly used traditional Chinese medicine extract with antitussive, expectorant, and anti-inflammatory effects.
Glycyrrhiza Extract
Applications
Raw material for compound glycyrrhiza tablets, Naolejing, compound aluminium bismuth citrate, and Huoxiang Zhengqi oral solution
Highlights
Pharmacological effects
Glycyrrhiza Extract is an effective component extracted from licorice with anti-inflammatory, anti-allergic, antitussive and expectorant effects.
Monoammonium Glycyrrhizinate S
Applications
Raw material for anti-inflammatory, detoxifying, antitussive, and anti-peptic ulcer drugs
Highlights
Pharmacological effects
Monoammonium Glycyrrhizinate S is a derivative of glycyrrhizic acid with stronger anti-inflammatory, detoxifying, and liver-protecting effects, serving as an important pharmaceutical raw material.
From registration support and clinical supply to quality assurance, the platform is designed to support both development and commercialization of human pharmaceutical products.
Both China NMPA and international GMP certifications support global pharmaceutical registration requirements.
Provides complete regulatory packages including COA, DMF and stability documentation.
Kilogram to ton-scale production supports clinical trials and commercial-stage supply planning.
Full-process CDMO support from development transfer to commercial manufacturing.
A mature quality management system keeps key product indicators consistent across batches.
Strict confidentiality practices protect client intellectual property and commercial know-how.
A focused set of therapeutic scenarios covering respiratory care, gastrointestinal treatment and oncology-adjacent support applications.
Ingredients for cough relief, anti-allergy care and chronic bronchitis formulations.
Suitable for ulcer, hepatitis and enteritis-related therapeutic product development.
Supports tumor adjuvant therapy and immunomodulation-oriented pharmaceutical formulations.
Contact us for drug registration support, clinical supply solutions, or CDMO partnership consultation.